Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson's Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy.

Parkinson’s disease cholinergic innervation multiple system atrophy nucleus basalis of Meynert progressive supranuclear palsy subcortical dementia voxel-based morphometry

Journal

Frontiers in aging neuroscience
ISSN: 1663-4365
Titre abrégé: Front Aging Neurosci
Pays: Switzerland
ID NLM: 101525824

Informations de publication

Date de publication:
2022
Historique:
received: 10 01 2022
accepted: 24 02 2022
entrez: 18 4 2022
pubmed: 19 4 2022
medline: 19 4 2022
Statut: epublish

Résumé

To study T1-weighted magnetic resonance images from patients with progressive supranuclear palsy (PSP, Significantly lower nbM volumes in patients with PSP and PD compared to HC or patients with MSA were found. No significant correlations between MMSE and nbM volumes were detected in any of the subgroups. No significant correlations were found between clinical scores and nbM volumes in PSP or other groups. nbM volumes were reduced both in PD and PSP but not in MSA. The lack of significant correlations between nbM and cognitive measures suggests that other factors, such as frontal atrophy, may play a more important role than subcortical cholinergic atrophy in PSP patients. These results may indicate that other drug-targets are needed to improve cognitive function in PSP patients.

Identifiants

pubmed: 35431891
doi: 10.3389/fnagi.2022.851788
pmc: PMC9012106
doi:

Types de publication

Journal Article

Langues

eng

Pagination

851788

Informations de copyright

Copyright © 2022 Rogozinski, Klietz, Respondek, Oertel, Grothe, Pereira and Höglinger.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurol Sci. 2017 Sep 15;380:182-186
pubmed: 28870563
Neurology. 2021 Feb 2;96(5):e684-e697
pubmed: 33199437
Ann Neurol. 1985 Feb;17(2):163-70
pubmed: 3883886
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Neurosci Biobehav Rev. 2018 Oct;93:38-56
pubmed: 29944959
Acta Neuropathol. 1983;61(2):157-60
pubmed: 6637400
Postgrad Med J. 1988 May;64(751):345-51
pubmed: 3059338
J Am Geriatr Soc. 1992 Sep;40(9):922-35
pubmed: 1512391
Ann Neurol. 1989 Sep;26(3):404-7
pubmed: 2802540
Mov Disord. 2014 Apr 15;29(5):684-93
pubmed: 24757116
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Neurology. 1996 Jul;47(1):1-9
pubmed: 8710059
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Brain. 2007 Jun;130(Pt 6):1552-65
pubmed: 17405767
Arch Neurol. 1986 Oct;43(10):991-5
pubmed: 3753274
Arch Clin Neuropsychol. 2013 Mar;28(2):104-13
pubmed: 23127882
Acta Neuropathol. 2003 Feb;105(2):117-24
pubmed: 12536222
Neuroimage. 2011 Apr 1;55(3):954-67
pubmed: 21216294
J Neurol Neurosurg Psychiatry. 1974 Feb;37(2):121-30
pubmed: 4819905
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Front Aging Neurosci. 2021 Mar 11;13:619543
pubmed: 33776742
Mov Disord. 2004 Dec;19(12):1391-402
pubmed: 15452868
J Neurol. 2018 Nov;265(11):2602-2613
pubmed: 30178175
Mov Disord. 2007 Aug 15;22(11):1594-600
pubmed: 17534953
Parkinsonism Relat Disord. 2022 Jan;94:89-95
pubmed: 34896929
J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):571-5
pubmed: 17178818
Neurology. 2000 Dec 12;55(11):1621-6
pubmed: 11113214
Neurobiol Dis. 2020 Jun;139:104831
pubmed: 32145376
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):454-6
pubmed: 16543521
J Neurol Neurosurg Psychiatry. 1998 Aug;65(2):155-63
pubmed: 9703164
Science. 1982 Jul 30;217(4558):408-14
pubmed: 7046051
Can J Neurol Sci. 1986 Nov;13(4 Suppl):435-40
pubmed: 3791059
J Neurol Sci. 2017 Mar 15;374:26-31
pubmed: 28088312
Lancet Neurol. 2017 Jul;16(7):552-563
pubmed: 28653647
Neurosci Lett. 1984 Jan 27;44(1):37-42
pubmed: 6717850
Brain Res. 1988 Jun 28;454(1-2):275-81
pubmed: 3409011
Parkinsonism Relat Disord. 2021 Sep;90:90-97
pubmed: 34418761
Acta Neuropathol. 1983;61(2):101-8
pubmed: 6637393
Brain. 2018 May 1;141(5):1501-1516
pubmed: 29701787
Front Aging Neurosci. 2021 Nov 01;13:763331
pubmed: 34790113
JAMA Neurol. 2018 Feb 1;75(2):169-178
pubmed: 29255885
J Neurol Neurosurg Psychiatry. 2013 May;84(5):544-51
pubmed: 23303961
J Neurol. 2015 Sep;262(9):2042-8
pubmed: 26070289
Acta Neuropathol. 2015 Apr;129(4):527-40
pubmed: 25633602
J Neuroimaging. 2020 Nov;30(6):786-792
pubmed: 33405336
Mov Disord. 2018 Apr;33(4):651-652
pubmed: 29322548
Brain. 2018 Jan 1;141(1):165-176
pubmed: 29228203
Mov Disord. 2020 May;35(5):825-832
pubmed: 31971293
Acta Neurol Scand. 2001 Feb;103(2):123-5
pubmed: 11227131
J Alzheimers Dis. 2014;40(3):687-700
pubmed: 24503619

Auteurs

Sophia Rogozinski (S)

Department of Neurology, Hanover Medical School, Hanover, Germany.

Martin Klietz (M)

Department of Neurology, Hanover Medical School, Hanover, Germany.

Gesine Respondek (G)

Department of Neurology, Hanover Medical School, Hanover, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Wolfgang H Oertel (WH)

Department of Neurology, Philipps University of Marburg, Marburg, Germany.

Michel J Grothe (MJ)

Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.

Joana B Pereira (JB)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.
Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.

Günter U Höglinger (GU)

Department of Neurology, Hanover Medical School, Hanover, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

Classifications MeSH